ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 26 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.55 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,198 | -26.3% | 6,206 | +1.0% | 0.00% | – |
| Q2 2023 | $21,988 | -89.8% | 6,142 | -93.8% | 0.00% | – |
| Q1 2023 | $216,112 | +67.7% | 99,134 | +825.4% | 0.00% | – |
| Q4 2022 | $128,865 | +138.6% | 10,712 | +27.3% | 0.00% | – |
| Q3 2022 | $54,000 | +157.1% | 8,415 | +84.9% | 0.00% | – |
| Q2 2022 | $21,000 | -19.2% | 4,551 | +50.1% | 0.00% | – |
| Q1 2022 | $26,000 | -86.7% | 3,031 | -77.8% | 0.00% | – |
| Q4 2021 | $195,000 | +650.0% | 13,676 | +1064.9% | 0.00% | – |
| Q3 2021 | $26,000 | -92.7% | 1,174 | -95.6% | 0.00% | – |
| Q2 2021 | $357,000 | +1883.3% | 26,681 | +1396.4% | 0.00% | – |
| Q1 2021 | $18,000 | +1700.0% | 1,783 | +1250.8% | 0.00% | – |
| Q4 2020 | $1,000 | -95.8% | 132 | -98.6% | 0.00% | – |
| Q3 2020 | $24,000 | +60.0% | 9,359 | +132.2% | 0.00% | – |
| Q2 2020 | $15,000 | -37.5% | 4,030 | -47.1% | 0.00% | – |
| Q1 2020 | $24,000 | +2300.0% | 7,623 | +3711.5% | 0.00% | – |
| Q4 2019 | $1,000 | -83.3% | 200 | -88.5% | 0.00% | – |
| Q3 2019 | $6,000 | -14.3% | 1,734 | -9.8% | 0.00% | – |
| Q2 2019 | $7,000 | +40.0% | 1,923 | +56.3% | 0.00% | – |
| Q1 2019 | $5,000 | -44.4% | 1,230 | -56.0% | 0.00% | – |
| Q4 2018 | $9,000 | -43.8% | 2,797 | -12.4% | 0.00% | – |
| Q3 2018 | $16,000 | -73.8% | 3,193 | -60.9% | 0.00% | – |
| Q2 2018 | $61,000 | +7.0% | 8,166 | -7.4% | 0.00% | – |
| Q1 2018 | $57,000 | -63.7% | 8,816 | -49.4% | 0.00% | – |
| Q4 2017 | $157,000 | +528.0% | 17,429 | +601.7% | 0.00% | – |
| Q3 2017 | $25,000 | +1150.0% | 2,484 | +728.0% | 0.00% | – |
| Q2 2017 | $2,000 | -33.3% | 300 | -21.7% | 0.00% | – |
| Q1 2017 | $3,000 | -62.5% | 383 | -71.8% | 0.00% | – |
| Q4 2016 | $8,000 | -42.9% | 1,359 | -28.7% | 0.00% | – |
| Q3 2016 | $14,000 | +180.0% | 1,906 | +208.9% | 0.00% | – |
| Q2 2016 | $5,000 | -37.5% | 617 | -51.9% | 0.00% | – |
| Q1 2016 | $8,000 | +60.0% | 1,284 | +108.1% | 0.00% | – |
| Q4 2015 | $5,000 | +66.7% | 617 | 0.0% | 0.00% | – |
| Q3 2015 | $3,000 | -85.0% | 617 | -81.9% | 0.00% | – |
| Q2 2015 | $20,000 | +17.6% | 3,401 | +26.4% | 0.00% | – |
| Q1 2015 | $17,000 | +142.9% | 2,691 | +77.4% | 0.00% | – |
| Q4 2014 | $7,000 | – | 1,517 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 315,301 | $1,444,000 | 1.50% |
| Private Portfolio Partners LLC | 54,010 | $247,366 | 0.07% |
| Knoll Capital Management, LLC | 20,000 | $92,000 | 0.05% |
| Urban Wealth Management, LLC | 2,858 | $13,000 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 100,216 | $459,000 | 0.04% |
| XTX Topco Ltd | 18,174 | $83,000 | 0.03% |
| Rossmore Private Capital | 40,661 | $186,000 | 0.03% |
| Ergoteles LLC | 224,700 | $1,029,000 | 0.03% |
| ETF MANAGERS GROUP, LLC | 87,365 | $393,000 | 0.01% |
| Belvedere Trading LLC | 40,690 | $343,000 | 0.01% |